Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Quantum-Si to Participate at Two Upcoming Investor Conferences
-
Electromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
Nuwellis Announces Board of Directors Transition
-
SunOpta Inc. to Participate in Upcoming Investor Conferences
-
Form 8.3 - [Sopheon plc - Opening Declaration - 31 03 2023] - (CGAML)
-
Pulmonx to Participate at Upcoming Investor Conferences
-
Odey Asset Management to close - website statement
-
CANACCORD GENUITY GROUP INC. ACCESS TO SECOND QUARTER FISCAL 2024 RESULTS INFORMATION
-
Annovis Bio Inc. (ANVS) Prices 1.25M Share Offering at $6/sh
-
Annovis Bio Announces Pricing of $7.5 Million Public Offering
-
Final Results
-
Annovis Bio Inc. (ANVS) Announces Proposed Share Offering
-
Annovis Bio Announces Launch of Proposed Public Offering
-
New Found Gold Corp. Announces C$56 Million Bought Deal Financing
-
Commerce Resources Corp. Announces Closing of Over-Subscribed Private Placement of Units to Raise Gross Proceeds of $5,453,980
-
Talkspace to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
-
Talkspace to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
-
Canaccord Genuity Starts Inventiva SA (IVA) at Buy
-
Form 8.3 - [EMIS GROUP PLC 26 10 2023] - (CGWL)
-
Canaccord Genuity Starts WA1 Resources Ltd (WA1:AU) at Spec. Buy
-
Endurance Gold Closes Second Tranche and Provides Project Update
-
Absci to Participate in Upcoming Investor Conferences
-
Form 8.3 - [EMIS GROUP PLC 24 10 2023] - (CGWL)
-
Arrow's Exercise of Warrants and Total Voting Rights
-
Ninepoint Partners Closes 2023 Short Duration Flow-Through LP With Over $20 Million In Proceeds
-
Edison Lithium Announces Closing of Non-Brokered Private Placement
-
Harpoon Therapeutics Inc. (HARP) Announces Up to $150 Million Private Placement
-
Harpoon Therapeutics Announces Up to $150 Million Private Placement
-
Form 8.3 - [EMIS GROUP PLC 20 10 2023] - (CGWL)
-
Form 8.3 - [EMIS Group plc - 19 10 2023] - (CGWL)
-
Tesla (TSLA) shares drop 7% in early trading
-
Form 8.3 - [KIN & CARTA PLC - 18 10 2023 - Opening Declaration] - (CGAML)
-
Tesla CEO Musk's demand warning sparks selloff in EV stocks
-
Form 8.3 - [EMIS GROUP PLC 18 10 2023] - (CGWL)
-
Tesla (TSLA) PT Lowered to $267 at Canaccord, 'Managing through a changing interest rate regime'
-
CORRECTION FROM SOURCE: Arrow Announces Exercise of Warrants by Largest Shareholders and Management and Provides an Update On RCE-6
-
American Hotel Income Properties REIT LP Announces Board Changes
-
Form 8.3 - [Form-8.3 EMIS GROUP PLC 17 10 2023] - (CGWL)
-
Arrow Announces Exercise of Warrants by Largest Shareholders and Management and Provides an Update on RCE-6
-
Bridger Aerospace Group (BAER) Announces Proposed $70M Follow-on Offering
-
Bridger Aerospace Announces $70 Million Proposed Public Follow-On Offering to Fund Growth Initiatives
-
$28,955,975 Raised on Initial Closing. Books now re-open for a final closing on November 8, 2023
-
HEALWELL AI Announces Closing of $8 Million Bought Deal Private Placement
-
Seelos Therapeutics (SEEL) Retains Canaccord Genuity in Connection with Review of Potential Partnerships and Collaborations
-
Seelos Therapeutics Retains Canaccord Genuity in Connection with Review of Potential Partnerships and Collaborations
-
Form 8.3 - [EMIS GROUP PLC 16 10 2023] - (CGWL)
-
Southern Energy Corp. Provides Operational Update
-
QuoteMedia Powers Stirlingshire Investments Trading Platform
-
Titanium Transportation Announces Normal Course Issuer Bid
-
Denison Completes US$55 Million Offering to Fund Long-Lead Procurement for Phoenix ISR Project

